New Delhi, September 18, 2026: Films released in Indian cinemas that depict the consumption, use or trafficking of narcotic drugs or psychotropic substances will now have to carry a specific anti-drug warning on screen, after the Union government amended the guidelines used by the Central Board of Film Certification (CBFC).
The Ministry of Information and Broadcasting notified the amended certification guidelines on September 16. Under the revised framework, relevant scenes must carry the warning: “Illicit Narcotics Destroy Health and Guarantees Imprisonment. Say No to Drugs.”
The change is more than a general instruction to filmmakers not to glorify drug use. The CBFC’s existing guidelines already required the Board to ensure that scenes tending to “encourage, justify or glamorise drug addiction” were not shown. What is new is the requirement for a standardised warning when narcotics or psychotropic substances are depicted in the specified circumstances.
That distinction matters for filmmakers because the government is moving from regulating the manner in which drug use is portrayed to also requiring an explicit message alongside the depiction.
What exactly has changed?
The revised guidelines apply to films being examined for public exhibition in India. The requirement covers scenes depicting or involving the consumption, use or trafficking of narcotic drugs or psychotropic substances.
The mandatory wording is:
“Illicit Narcotics Destroy Health and Guarantees Imprisonment. Say No to Drugs.”
The warning is therefore broader than a health message. It combines a warning about the health consequences of illicit narcotics with a reference to imprisonment.
Before this amendment, the certification guidelines already dealt directly with drugs. The CBFC was instructed to ensure that scenes encouraging, justifying or glamorising drug addiction were not shown. Similar principles exist for the glorification of violence and drinking, while the guidelines also cover sexual content, cruelty, public order, national security and India’s relations with foreign states.
The latest change does not replace those principles. It adds another compliance requirement where the specified drug-related content appears.
This is part of a wider policy covering screens beyond cinemas
The cinema rule did not emerge in isolation.
On August 20, the Information and Broadcasting Ministry issued an advisory concerning warnings about the harmful effects of drug abuse on private satellite television channels. On August 24, it issued a corresponding advisory for OTT platforms. The ministry’s official advisory register lists both measures.
The OTT direction asked platforms to prominently display an anti-drug warning when applicable. The new film-certification requirement effectively extends the same policy direction to theatrical films.
There was already a broader regulatory foundation for treating drug and substance abuse as an age-classification issue on streaming services. The government told Parliament in August that the Information Technology Rules, 2021 require OTT content to be classified using factors including themes, violence, nudity, sex, language, drug and substance abuse, and horror.
The ministry had also issued an earlier advisory to OTT publishers concerning content related to narcotic drugs and psychotropic substances, asking platforms to exercise due diligence and avoid presenting drug consumption as fashionable or socially acceptable.
Taken together, the measures show an effort to establish a more consistent anti-drug messaging policy across cinemas, television and streaming, even though those media operate under different regulatory frameworks.
What does this mean for film certification?
The CBFC is a statutory body under the Ministry of Information and Broadcasting. Films cannot be publicly exhibited in India without certification by the Board. Its certification process operates under the Cinematograph Act, the Cinematograph (Certification) Rules and guidelines issued by the Central government.
That makes the latest anti-drug provision different from a voluntary public-service campaign.
For a film containing scenes covered by the revised guideline, compliance becomes part of the certification framework.
This does not mean every reference to drugs automatically requires a scene to be deleted. The government’s reported amendment specifically introduces the warning for scenes involving consumption, use or trafficking, while the existing guideline separately deals with scenes that encourage, justify or glamorise drug addiction.
For producers, editors and post-production teams, that creates two distinct considerations: whether the portrayal itself complies with CBFC standards and whether the mandatory warning has been included where required.
The practical impact may be especially visible in crime dramas, gangster films, biographical stories, thrillers and narratives centred on addiction or narcotics trafficking, where drug-related scenes can be integral to the story rather than incidental.
Is this the same as the tobacco warning system?
There is an obvious comparison with the health warnings Indian audiences already encounter around smoking and tobacco imagery, but the legal and regulatory requirements should not simply be treated as identical.
The CBFC’s longstanding certification guidelines separately state that scenes tending to encourage, justify or glamorise tobacco consumption or smoking should not be shown.
India also has a separate statutory framework governing tobacco-related warnings in films and television programmes.
The new narcotics requirement resembles that broader policy approach in one important respect: a potentially harmful activity depicted as part of entertainment content is accompanied by an explicit warning to the viewer.
But the exact display requirements for the new narcotics warning should be read from the latest government notification rather than assumed from tobacco rules. Public reports confirming the amendment establish the prescribed wording and the types of drug-related scenes covered, but do not provide enough independently accessible detail to conclude that every technical requirement governing tobacco warnings—such as duration, placement or formatting—automatically applies to narcotics warnings.
CBFC rules themselves are changing
The anti-drug requirement arrives during a broader period of change in Indian film certification.
The Cinematograph (Certification) Rules, 2024 introduced age markers within the UA category. Films can now receive classifications including U, UA 7+, UA 13+, UA 16+ and A, allowing parents to make more age-specific viewing decisions.
The government told Parliament in March that the CBFC certified 71,963 films between 2020-21 and 2024-25, with 3,033 films certified with cuts or modifications in 2024-25 alone. It also said the average certification time had fallen to about 22 working days for feature films, compared with the prescribed maximum timeline of 48 working days under the 2024 rules.
The anti-drug amendment therefore joins a certification system that has increasingly combined content standards with more granular audience information.
There has also been an institutional change.
On September 16—the same date reported for the amended guidelines—the government announced the reconstitution of the CBFC for three years or until further orders. The newly constituted Board has 18 members, including actors Pankaj Tripathi, Suniel Shetty, Preity Zinta, Prosenjit Chatterjee, Pallavi Joshi and Roopali Ganguly, filmmaker Priyadarshan and musician Ricky Kej, among others.
The timing places the warning requirement alongside a wider reset in the certification body, although there is no evidence in the official announcement that the new Board itself initiated the anti-drug amendment.
Why the wording could matter creatively
For filmmakers, the important question is not simply whether an anti-drug message exists, but how frequently it has to appear and how it interacts with storytelling.
A film about narcotics trafficking can contain dozens of scenes involving drugs. A story about addiction may require repeated depictions because drug use is central to the character’s journey.
If a warning must accompany each qualifying scene, its visual presence could become significant for editing and composition. If implementation permits a less intrusive approach, the creative impact would be smaller.
The publicly accessible reporting reviewed for this article confirms that covered scenes must carry the warning, but does not provide enough detail to independently establish every implementation scenario filmmakers may encounter. Producers submitting films for certification will therefore need to follow the precise CBFC and ministry instructions applicable during examination rather than extrapolating from earlier tobacco-warning practices.
There is also a distinction between depiction and endorsement.
A film can depict drug addiction critically, showing severe consequences, without encouraging drug use. The earlier CBFC guideline was primarily concerned with encouragement, justification or glamorisation. The new rule means that even a narrative depicting narcotics as destructive can still fall within the warning requirement when it shows the covered conduct.
That expands the practical reach of the policy.
A warning does not replace age classification
The amendment should also not be confused with an age rating.
A warning communicates a specific government message about narcotics. A certification category tells audiences which age group a film is considered appropriate for.
Under the current system, UA markers distinguish between guidance for children below seven, 13 and 16, while an A certificate restricts public exhibition to adults. The government has specifically identified addictive habits and other mature material among the factors that can influence age classification.
A film could therefore comply with the anti-drug warning requirement and still receive a more restrictive certificate because of the overall nature and impact of its content.
For audiences, that is an important distinction: the warning is not a substitute for the CBFC’s assessment of the film as a whole.
What is confirmed — and what remains unclear
The core development is confirmed across government-linked material and multiple reports: the Centre has amended film-certification guidelines so that scenes involving the consumption, use or trafficking of narcotic drugs or psychotropic substances carry the prescribed anti-drug warning. The change was notified on September 16, 2026.
It is also independently verifiable that the CBFC’s earlier published guidelines prohibited portrayals tending to encourage, justify or glamorise drug addiction, without the specific warning now being reported.
What could not be independently established from the publicly accessible primary material reviewed for this article is the full technical presentation standard for every possible scene: for example, precise screen position, font size, minimum duration, whether continuous scenes require repeated display, and how the rule will be handled in already-certified films seeking re-release.
Those details should not be inferred from tobacco regulations unless the government explicitly incorporates the same standards.
For producers, that implementation guidance may ultimately be as consequential as the warning itself. The policy direction, however, is already clear: when Indian cinema depicts narcotics, the government wants the screen to communicate not only the story, but an explicit warning about drugs as well.
